The position of endoscopic procedures in the treatment of obesity

Current Clinical Pharmacology

Volumn 8, Issue 3, 2013, Pages 238-246

  Štimac, Davor ^a   Majanović, Sanja Klobučar ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Bariatric surgery; Endoscopic obesity treatment; Intragastric balloon; Roux en y gastric bypass; Transoral gastroplasty (TOGA)

Indexed keywords

RIMONABANT; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BEHAVIOR CHANGE; BILIOPANCREATIC BYPASS; CONSERVATIVE TREATMENT; DIET; DUODENOJEJUNAL BYPASS SLEEVE; EARLY INTERVENTION; ENDOLUMINAL VERTICAL GASTROPLASTY; ENDOSCOPIC SURGERY; EXERCISE; GASTRIC BALLOON; GASTRIC BANDING; GASTROINTESTINAL SURGERY; GASTROPLASTY; HUMAN; INTERMETHOD COMPARISON; OBESITY; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; SURGICAL STAPLING; SUTURING METHOD; TRANSORAL ENDOSCOPIC RESTRICTIVE IMPLANT SYSTEM; TRANSORAL GASTROPLASTY; WEIGHT REDUCTION;

BARIATRIC SURGERY; DUODENUM; ENDOSCOPY; GASTRIC BALLOON; GASTRIC BYPASS; GASTROPLASTY; HUMANS; JEJUNUM; OBESITY;

EID: 84882744777     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574884711308030011     Document Type: Review

References (46)

1. Overweight, obesity and health risk. National Task Force on the prevention and Treatment of Obesity. Arch Intern Med 2000; 160: 898-904.
2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187-93.
3. World Health Organ Tech Rep Ser. Obesity: preventing and managing the global epidemic. Report of a WHO consultation 2000; 894: 1-253.
4. Hankey CR. Management of obesity: Weight-loss interventions in the treatment of obesity. Proc Nutr Soc 2010; 69(1): 34-8.
5. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med 2009; 122(3): 248-56.
6. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol 2011; 8: 429-37.
7. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292(14): 1724-37.
8. Morino M, Troppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13871 morbidly obese patients from a national registry. Ann Surg 2007; 246: 1002-7.
9. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and metaanalysis. Surgery 2007; 142(4): 621-32
10. Allen JW. Laparoscopic gastric band complications. Med Clin North Am 2007; 91: 485-97.
11. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009; CD003641.
12. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: Effects of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150: 94-103.
13. Coté GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc 2009; 70(5): 991-9.
14. Kumar N, Thompson CC. Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011; 27(5): 407-11.
15. Thompson CC. Endoscopic therapy of obesity: a new paradigm in bariatric care. Gastrointest Endosc 2010; 72: 505-7.
16. Ryou M, Ryan MC, Thompson CC. Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am 2011; 21(3): 315-33.
17. Sacks FM, Bray GA, Carey VJ, Smith SR, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360(9): 859-73.
18. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated metaanalysis. BMJ 2007; 335:1194-9.
19. ASGE/ASMBS Task force on endoscopic bariatric therapy. A pathway to endoscopic bariatric therapies. Gastrointest Endosc 2011; 74(5): 943-53.
20. Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian Experience with 2515 patients. Obes Surg 2005; 15: 1161-4.
21. Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics intragastric balloon (BIB). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011; 21(1): 5-9.
22. Stimac D, Majanovic SK, Turk T, Kezele B, Licul V, Orlic ZC. Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg 2011; 21(5): 551-5.
23. Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009; 41(7): 575-80.
24. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 Intragastric balloons: What Happens 5 Years Thereafter? Obes Surg 2012; 22(6): 896-903.
25. Melissas J, Mouzas J, Fills D, et al. The intragastric balloon - smoothing the path to bariatric surgery. Obes Surg 2006; 16: 897-902.
26. Spyropolos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Relat Dis 2007; 3: 78-83.
27. Zerrweck C, Maunoury V, Caiazzo R, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg 2012; 22(5): 777-82.
28. Kadirkamanathan SS, Evans DF, Gong F, Yazaki E, Scott M, Swain CP. Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc 1996; 44: 133-43.
29. Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am 2003; 13: 89-101.
30. Schwartz MP, Wellink H, Gooszen HG, et al. Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut 2007; 56: 20-8.
31. Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008; 68: 51-8.
32. Thompson CC, Brethauer SA, Chand B, et al. Transoral Gastric Volume Reduction as an intervention for Weight Management (TRIM) Multicenter Feasibility Study: a report of early outcomes. Gastroenterology 2009; 136:A-384.
33. Devière J, Ojeda Valdes G, Cuevas Herrera L et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surg Endosc 2008; 22: 589-98.
34. Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40: 406-13.
35. Familiari P, Costamagna G, Bléro D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc 2011; 74(6): 1248-58.
36. Chiellini C, Iaconelli A, Familiari P, et al. Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis 2010; 20(3): 202-7.
37. de Jong K, Mathus-Vliegen EMH, Veldhuyzen EAML, et al. Short-term safety and efficacy of the Trans-Oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc 2010; 72: 497-504.
38. Verlaan T, de Jong K, Mathus-Vliegen EM, et al. Evaluation of the safety and efficacy results of the Trans-Oral Endoscopic Restrictive System (TERIS) for the treatment of obesity at six months. Presented at Digestive Disease Week 2011; Mo270.
39. Ellsmere JC, Thompson CC, Brugge WR, et al. Endoscopic Interventions for Weight Loss Surgery. Obesity 2009; 17: 929-33.
40. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008, 4: 55-9.
41. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for preoperative weight loss in bariatric suregry. Surg Endosc 2009; 23: 650-6.
42. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010; 251(2): 236-43.
43. Gersin KS, Rothstein RI, Rosenthal J, et al. Open-label, shamcontrolled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71(6): 976-82.
44. Gagner M. Intragastric balloons appear safer and better than the endoscopic duodenojejunal bypass liners (DJBL) for preoperative weight loss in bariatric surgery. Gastrointest Endosc 2011; 73(4): 850-1.
45. De Moura EG, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2012; 14(2): 183-9.
46. Sandler BJ, Rumbaut R, Swain CP, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc 2011; 25(9): 3028-33.